Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011, Article ID 951616, 7 pages
http://dx.doi.org/10.1155/2011/951616
Review Article

Drug Testing for Newborn Exposure to Illicit Substances in Pregnancy: Pitfalls and Pearls

1Section for Children at Risk, Department of Pediatrics, University of Arkansas for Medical Sciences, 1 Children's Way, Slot 512-24A, Little Rock, AR 72202, USA
2Section for Pharmacology and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA
3Section for Neonatology, Department of Pediatrics, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 512-B, Little Rock, AR 72205, USA

Received 1 September 2010; Accepted 19 May 2011

Academic Editor: Anne Bartu

Copyright © 2011 Karen J. Farst et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [24 citations]

The following is the list of published articles that have cited the current article.

  • Caroline Cooper, “Drug Courts - Just the Beginning: How to Get Other Areas of Public Policy in Sync? Addressing Continuing Collateral Consequences for Drug Offenders,” SSRN Electronic Journal, . View at Publisher · View at Google Scholar
  • Karen Farst, and Branson B. Bolden, “Substance-Exposed Infants and Children: Forensic Approach,” Clinical Pediatric Emergency Medicine, vol. 13, no. 3, pp. 221–228, 2012. View at Publisher · View at Google Scholar
  • Steven W. Cotten, “Drug Testing in the Neonate,” Clinics In Laboratory Medicine, vol. 32, no. 3, pp. 449–+, 2012. View at Publisher · View at Google Scholar
  • Elena Lendoiro, Eva Gonzalez-Colmenero, Ana Concheiro-Guisan, Ana de Castro, Angelines Cruz, Manuel Lopez-Rivadulla, and Marta Concheiro, “Maternal Hair Analysis for the Detection of Illicit Drugs, Medicines, and Alcohol Exposure During Pregnancy,” Therapeutic Drug Monitoring, vol. 35, no. 3, pp. 296–304, 2013. View at Publisher · View at Google Scholar
  • Marina Villarreal, and Silvina Re, “Detection of illicit drugs in urine in the Division of Neonatology Hospital Molas in La Pampa,” Archivos Argentinos de Pediatria, vol. 111, no. 3, pp. 232–236, 2013. View at Publisher · View at Google Scholar
  • Michael K. Lindsay, and Erin Burnett, “The Use of Narcotics and Street Drugs During Pregnancy,” Clinical Obstetrics and Gynecology, vol. 56, no. 1, pp. 133–141, 2013. View at Publisher · View at Google Scholar
  • Ludmila N. Bakhireva, Renate D. Savich, Dennis W. Raisch, Sandra Cano, Robert D. Annett, Lawrence Leeman, Mahek Garg, Chelsea Goff, and Daniel D. Savage, “The Feasibility and Cost of Neonatal Screening for Prenatal Alcohol Exposure by Measuring Phosphatidylethanol in Dried Blood Spots,” Alcoholism: Clinical and Experimental Research, vol. 37, no. 6, pp. 1008–1015, 2013. View at Publisher · View at Google Scholar
  • Margaret Eichel, and Tonya Johannemann, “Implementation of Universal Maternal Drug Screening to Identify Neonatal Abstinence Syndrome Candidates,” Newborn and Infant Nursing Reviews, 2013. View at Publisher · View at Google Scholar
  • Kelly E. Wood, Lori L. Sinclair, Carolyn D. Rysgaard, Frederick G. Strathmann, Gwendolyn A. McMillin, and Matthew D. Krasowski, “Retrospective analysis of the diagnostic yield of newborn drug testing,” Bmc Pregnancy and Childbirth, vol. 14, 2014. View at Publisher · View at Google Scholar
  • S C Jaques, A Kingsbury, P Henshcke, C Chomchai, S Clews, J Falconer, M E Abdel-Latif, J M Feller, and J L Oei, “Cannabis, the pregnant woman and her child: weeding out the myths,” Journal of Perinatology, 2014. View at Publisher · View at Google Scholar
  • Lisa Clark, and Annie Rohan, “Identifying And Assessing The Substance-Exposed Infant,” Mcn-The American Journal Of Maternal-Child Nursing, vol. 40, no. 2, pp. 87–95, 2015. View at Publisher · View at Google Scholar
  • Rebecca Stone, “Pregnant women and substance use: fear, stigma, and barriers to care,” Health & Justice, vol. 3, no. 1, 2015. View at Publisher · View at Google Scholar
  • Karen McQueen, and Jodie Murphy-Oikonen, “Neonatal Abstinence Syndrome,” New England Journal of Medicine, vol. 375, no. 25, pp. 2468–2479, 2016. View at Publisher · View at Google Scholar
  • Kendra L. Palmer, Kelly E. Wood, and Matthew D. Krasowski, “Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center,” Clinical Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Meagan Stabler, Peter Giacobbi, Ilana Chertok, Leann Long, Lesley Cottrell, and Panitan Yossuck, “Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother–Infant Dyads,” Therapeutic Drug Monitoring, vol. 39, no. 6, pp. 640–647, 2017. View at Publisher · View at Google Scholar
  • Hannah E Laue, Raphael Cassoulet, Nadia Abdelouahab, Yasmine K Serme-Gbedo, Anne-Sandrine Desautels, Kasey J M Brennan, Jean-Philippe Bellenger, Heather H Burris, Brent A Coull, Marc G Weisskopf, Larissa Takser, and Andrea A Baccarelli, “Association Between Meconium Acetaminophen and Childhood Neurocognitive Development in GESTE, a Canadian Cohort Study,” Toxicological Sciences, 2018. View at Publisher · View at Google Scholar
  • Hayley R. Price, Abby C. Collier, and Tricia E. Wright, “Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Nicole A. Bailey, and Magaly Diaz-Barbosa, “Effect of Maternal Substance Abuse on the Fetus, Neonate, and Child,” Pediatrics in Review, vol. 39, no. 11, pp. 550–559, 2018. View at Publisher · View at Google Scholar
  • Fang Wu, Triniti L. Jensen, and Gwendolyn A. McMillin, “Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method,” LC-MS in Drug Analysis, vol. 1872, pp. 211–222, 2018. View at Publisher · View at Google Scholar
  • Courtney Townsel, Jonathan M. Covault, Naveed Hussain, Cheryl Oncken, Christopher Nold, and Winston A. Campbell, “Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome,” The Journal of Maternal-Fetal & Neonatal Medicine, pp. 1–7, 2019. View at Publisher · View at Google Scholar
  • Patricia Yam, Laverne Lok, John Eastwood, Catherine Maher, Meredith Ward, Sara Clews, Janet Falconer, and Ju Lee Oei, “Validation of hospital discharge coding for neonatal abstinence syndrome,” Acta Paediatrica, 2019. View at Publisher · View at Google Scholar
  • Fábio Martins, David Oppolzer, Catarina Santos, Mário Barroso, and Eugenia Gallardo, “Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome—A Review of the Literature,” Toxics, vol. 7, no. 1, pp. 9, 2019. View at Publisher · View at Google Scholar
  • Matthew Grossman, and Adam Berkwitt, “Neonatal Abstinence Syndrome,” Seminars in Perinatology, 2019. View at Publisher · View at Google Scholar
  • Esther Papaseit, Robert Muga, Paola Zuluaga, Arantza Sanvisens, and Magí Farré, “Meconium Biomarkers of Prenatal Alcohol Exposure,” Neuroscience of Alcohol, pp. 585–594, 2019. View at Publisher · View at Google Scholar